Clarivate Adds German Hospital Prescribing Insights to Solution

News
Article

New data provides researchers with aggregated, anonymized specialty prescribing habits across brands and diseases.

Clarivate has released German hospital prescribing insights within The Clarivate Patient Data Intelligence (CPDI), which includes new aggregated, anonymized data product to provide clarity on this market’s trends, patient characteristics, and specialty prescribing habits across brands and diseases.

The self-service CPDI platform positions Clarivate as a leading provider of real-world data solutions in Europe, as well as providing pharma companies the ability to identify specialties they are most interested in and optimize commercial targeting in key European markets, including Italy, France, Spain and Germany.

Zoe Barker, Vice President of Product, Clarivate, said, in a press release, "Significant investment of resources is required to analyze real world data products, particularly to understand the European market landscape, patient behavior, and prescribing habits. Such investment can delay the success of drug launches. With the addition of German hospital prescribing insights, Clarivate continues to deliver market leading intelligence that empowers life science and healthcare organizations to create a healthier tomorrow."

Reference: Clarivate Enhances Patient Data Intelligence Solution with Addition of German Hospital Prescribing Insights. London, July 27, 2023 /PRNewswire.

Related Videos
Jason Tate, FSP Talent Strategy Lead, PPD, part of Thermo Fisher Scientific
Related Content